Healthcare stocks were lower this afternoon, with the NYSE Healthcare Sector Index slipping about 1.2% and shares of healthcare companies in the S&P 500 also declining about 1.2% as a group.
In company news, shares of bluebird bio Inc. ( BLUE ) slid Tuesday after announcing plans for a $100 million public offering of its common stock.
At Monday's closing price of $37.62 a share, the biotech company working on treatments for rare genetic disorders and other orphan diseases would issue around 2.66 million new shares, diluting existing shareholders by nearly 11%.
BLUE shares recently were down nearly 9% at $34.37 each, earlier sinking to an intra-day low of $33.88 a share. The stock has a 52-week range of $17.03 to $41.75 a share, rising 19.5% over the past 12 months.
In other sector news,
(+) NURO, (+30.7%) FDA clears the company to begin over-the-counter sales of its wearable device using electrical stimulation of sensory nerves to treat chronic pain.
(-) IPCI, (-11.3%) Reports Q2 net loss of $3.1 million, or $0.14 per share, compared with a $1.8 million net loss during the same quarter last year. Revenue totaled $1.5 million during the quarter; it didn't record any revenue last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.